This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by identifying potential nutraceutical applications of bioactive compounds for prevention and treatment of Alzheimer's Disease.
This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by considering the neuroprotective properties of nutraceuticals such as soy, peanuts, and ginsenoside Rg1.
As we enter the ninth year since the adoption of the UN Sustainable Development Goals (SDGs) in 2015, the pressing need to meet these ambitious objectives becomes ever more evident.
